Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3800423
Max Phase: Preclinical
Molecular Formula: C40H60Cl2F2N9O13P
Molecular Weight: 1014.85
Molecule Type: Small molecule
Associated Items:
ID: ALA3800423
Max Phase: Preclinical
Molecular Formula: C40H60Cl2F2N9O13P
Molecular Weight: 1014.85
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@H](NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)CCCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)Nc1cc(F)c(COP(N)(=O)N(CCCl)CCCl)c(F)c1)C1CCCCC1
Standard InChI: InChI=1S/C40H60Cl2F2N9O13P/c1-22(47-39(63)31-18-25(55)19-53(31)33(57)8-5-9-34(58)59)36(60)50-30(20-54)38(62)51-35(23-6-3-2-4-7-23)40(64)49-29(10-11-32(45)56)37(61)48-24-16-27(43)26(28(44)17-24)21-66-67(46,65)52(14-12-41)15-13-42/h16-17,22-23,25,29-31,35,54-55H,2-15,18-21H2,1H3,(H2,45,56)(H2,46,65)(H,47,63)(H,48,61)(H,49,64)(H,50,60)(H,51,62)(H,58,59)/t22-,25+,29-,30-,31-,35-,67?/m0/s1
Standard InChI Key: ZFPRXVFGPPXDSA-CQAUXZAQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1014.85 | Molecular Weight (Monoisotopic): 1013.3393 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Wu X, Hu L.. (2016) Design and synthesis of peptide conjugates of phosphoramide mustard as prodrugs activated by prostate-specific antigen., 24 (12): [PMID:27156193] [10.1016/j.bmc.2016.04.035] |
Source(1):